CTOs on the Move

Saint Luke`s Duluth, Minnesota

www.slhduluth.com

 
St. Luke`s, a regional health care system, offers a comprehensive continuum of care serving the 17-county region of northeastern Minnesota, northwestern Wisconsin and the Upper Peninsula of Michigan. The system includes St. Luke`s Hospital in Duluth, Minnesota, Lake View Hospital in Two Harbors, Minnesota, and 11 primary and 27 specialty clinics. Primary care clinics are located in Duluth, Hermantown, Hibbing, Two Harbors, Mountain Iron and Silver Bay, Minnesota, and Ashland and Superior, Wisconsin. Urgent care and Q Care express medical services are also available. St. Luke`s is designated by the American College of Surgeons and the state of Minnesota Department ...
  • Number of Employees: 1K-5K
  • Annual Revenue: $250-500 Million

Executives

Name Title Contact Details
Wendy Follis
Director of Information Technology Profile
Chris Sorenson
Vice President and Chief Information Officer Profile

Similar Companies

ClearCorrect

ClearCorrect works with more than 14,000 doctors, making it a leading manufacturer of clear aligners. The company offers a more affordable and doctor-friendly approach, including a phase-based system to enhance flexibility and control for doctors. It just recently celebrated its 7th year anniversary and has international plans on the horizon.

Island Gym and Fitness

Island Gym and Fitness is a Absecon, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Virbac Corporation

Virbac Corporation is a Fort Worth, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

BIO 101

BIO 101 is a Vista, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Celator Pharmaceuticals

Celator Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that is transforming the science of combination therapy and developing products to improve outcomes for patients with cancer. The Company is working to establish a new treatment paradigm in which rationally-designed, fully-integrated combination products replace combination regimens of individual agents. Celator`s proprietary technology platform, CombiPlex®, identifies the most effective synergistic ratio of the component drugs, optimizes the pharmacology of the drug combination prior to human clinical trials, allows simultaneous administration of the components as a single product and maintains the synergistic ratio of the components after administration thereby exposing tumor cells to the right amounts of drug for the right length of time.